Clinical Trial Update: Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing XELOX vs capecitabine alone in elderly patients with advanced gastric cancer was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• XELOX (capecitabine + oxaliplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer | Phase 3 | Status: WITHDRAWN